CHRM4 and inflammatory bowel disease: Although CHRM4 activation by acetylcholine in goblet cells has been demonstrated to regulate microbial sensing and antigen presentation in mice, and that the disruption of this process can lead to an inflammatory response [67], the role of this receptor in the pathophysiology of IBD is currently unknown.